RA
IDXX icon

Royce & Associates’s Idexx Laboratories IDXX Stock Holding History

Royce & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6
Closed -$1K – 1163
2018
Q4 		$1K Sell
6
-95,255
-100% -$19.5M ﹤0.01% 1142
2018
Q3 		$23.8M Sell
95,261
-49,057
-34% -$11.9M 0.16% 163
2018
Q2 		$31.5M Sell
144,318
-38,904
-21% -$8.02M 0.22% 117
2018
Q1 		$35.1M Sell
183,222
-48,382
-21% -$8.93M 0.25% 99
2017
Q4 		$36.2M Sell
231,604
-69,096
-23% -$10.9M 0.24% 101
2017
Q3 		$46.8M Sell
300,700
-15,600
-5% -$2.47M 0.31% 71
2017
Q2 		$51.1M Hold
316,300
– – 0.34% 61
2017
Q1 		$48.9M Sell
316,300
-66,600
-17% -$9.18M 0.32% 81
2016
Q4 		$44.9M Sell
382,900
-326,090
-46% -$37.2M 0.29% 93
2016
Q3 		$79.9M Sell
708,990
-154,822
-18% -$16.3M 0.53% 32
2016
Q2 		$80.2M Sell
863,812
-18,800
-2% -$1.61M 0.53% 32
2016
Q1 		$69.1M Sell
882,612
-325,110
-27% -$23.4M 0.44% 47
2015
Q4 		$88.1M Sell
1,207,722
-563,200
-32% -$40.2M 0.53% 33
2015
Q3 		$131M Buy
1,770,922
+154,300
+10% +$11.1M 0.7% 17
2015
Q2 		$104M Sell
1,616,622
-297,400
-16% -$20.6M 0.44% 45
2015
Q1 		$148M Sell
1,914,022
-75,600
-4% -$5.88M 0.56% 26
2014
Q4 		$148M Sell
1,989,622
-304,440
-13% -$21.3M 0.51% 33
2014
Q3 		$135M Sell
2,294,062
-113,760
-5% -$7.19M 0.46% 41
2014
Q2 		$161M Hold
2,407,822
– – 0.48% 37
2014
Q1 		$146M Sell
2,407,822
-582,800
-19% -$34.7M 0.43% 45
2013
Q4 		$159M Buy
2,990,622
+4,000
+0.1% +$211K 0.46% 39
2013
Q3 		$149M Sell
2,986,622
-283,200
-9% -$13.6M 0.44% 42
2013
Q2 		$147M Buy
+3,269,822
New +$143M 0.45% 36

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Royce & Associates's IDXX Position: Q1 2019 in Review

Royce & Associates sold out of Idexx Laboratories (IDXX) in Q1 2019, closing a stake of 6 shares — an estimated $1K sold.

Royce & Associates first reported a position in IDXX in Q2 2013 and held it in 23 quarters. The position peaked at $161M in Q2 2014. 685 funds tracked by Wall St. Rank hold IDXX as of Q1 2019.

  • Royce & Associates reported no remaining Idexx Laboratories position as of Q1 2019 after selling out during the quarter.
  • Royce & Associates sold 6 Idexx Laboratories shares in Q1 2019, an estimated $1K.
  • Royce & Associates first reported a position in Idexx Laboratories in Q2 2013 and held it in 23 quarters.
  • Royce & Associates's Idexx Laboratories position peaked at $161M in Q2 2014.
  • 685 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2019.

Based on Royce & Associates's 13F filing for Q1 2019, filed 9 May 2019.